Who founded Soteria Biotherapeutics, Inc.?

Soteria Biotherapeutics, Inc. was founded by Zachary B. Hill, Jim Wells in 2018.

Who are Soteria Biotherapeutics, Inc.'s investors?

Soteria Biotherapeutics, Inc.'s investors include 5AM Ventures, Novartis Venture Fund, Roche Venture Fund, Versant Ventures, BioGeneration Ventures, Westlake Village BioPartners.

Where is Soteria Biotherapeutics, Inc. headquartered?

Soteria Biotherapeutics, Inc. is headquartered in San Francisco, US.

Soteria Biotherapeutics, Inc.

San Francisco, US · Founded 2018 · 6 known investors

Find your way into Soteria Biotherapeutics, Inc.

320 people in our graph share verified history with the Soteria Biotherapeutics, Inc. team — schools, employers, funds. One of them is your warm intro.

Andrewunlockedknows Zachary Hill · together at University of Washington (overlapped)

×4knows the team · via University of Washington

×4knows the team · via Ey

knows the team · via Antiva Biosciences

knows the team · via Exelixis

knows the team · via University of California, San Francisco

Soteria Biotherapeutics develops protein-based biotherapeutics and small molecules using its LITE Switch technology platform for drug discovery and development across oncology, immune-oncology, and inflammatory disease indications.

Biotech Deep Tech Healthtech Medical Devices Wellness & Fitness

Founders & leadership

Soteria Biotherapeutics, Inc. was founded in 2018 by Zachary B. Hill and Jim Wells.

Zachary B. HillSVP, Chief Scientific Officer and Co-founder

Jim WellsCo-founder, Scientific Advisory Board Chair

Kristine M Ball inChief Executive Officer2020–2022Executive Officer, Director at Antiva Biosciences

Zachary Hill inCo-Founder2018–2022Zachary Hill is VP of Discovery Chemistry at Montara Therapeutics, leading small molecule identification for their therapeutics platform. He has over 15 years of research experience in small molecule synthesis and protein engineering applied to therapeutic development, including doctoral training under Dustin Maly at the University of Washington and postdoctoral work with Jim Wells at UCSF.

Board

Nisha MaratheBoard director

David Allison inBoard directorManaging Director at Westlake Village BioPartners

Keno Gutierrez inBoard Member and Observer2018–2021General Partner at BioGeneration Ventures

David MorrisBoard director

Steve JamesBoard director

Momo WuBoard director

Investors · 6

5AM Ventures✓ verifiedBoston · $100K – $4M

Novartis Venture Fund✓ verifiedBasel · $5M – $25M

Roche Venture Fund✓ verifiedBasel · $648K – $3.2M

Versant Ventures✓ verifiedSan Francisco · $250K – $5M

BioGeneration VenturesreportedNaarden

Westlake Village BioPartnersreported · 2 sourcesLos Angeles · $100K – $5Mvia David Allison · board

Reported raises · per SEC filings

Form D private placements

▶$24.9MraisedMay 2021 · 8 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Nisha MaratheDirector
Kristine M BallExecutive Officer, Director
David AllisonDirector
Keno GutierrezDirector
David MorrisDirector
Steve JamesDirector
Momo WuDirector
Zachary HillExecutive Officer, Director

Offering amount: $42.2M
Amount sold: $24.9M
First sale: May 2021
Incorporated: Corporation, Delaware, 2018
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase I	2019	$299.6K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Soteria Biotherapeutics Raises $42M in Series A Financingfinsmes.com · May 2021

Discovering Biotech Startups: A map for Selling to Soteria Biotherapeuticsblog.zymewire.com · Mar 2020

Frequently asked questions

What does Soteria Biotherapeutics, Inc. do?: Soteria Biotherapeutics develops protein-based biotherapeutics and small molecules using its LITE Switch technology platform for drug discovery and development across oncology, immune-oncology, and inflammatory disease indications.
Who founded Soteria Biotherapeutics, Inc.?: Soteria Biotherapeutics, Inc. was founded by Zachary B. Hill, Jim Wells in 2018.
Who are Soteria Biotherapeutics, Inc.'s investors?: Soteria Biotherapeutics, Inc.'s investors include 5AM Ventures, Novartis Venture Fund, Roche Venture Fund, Versant Ventures, BioGeneration Ventures, Westlake Village BioPartners.
Where is Soteria Biotherapeutics, Inc. headquartered?: Soteria Biotherapeutics, Inc. is headquartered in San Francisco, US.